TURINOVA
TURINOVA Tablet by NovaTech Sciences contains Chlorodehydromethyltestosterone (CAS 2446‑23‑3). Trusted manufacturer, supplier, and exporter of pharmaceutical‑grade anabolic support for strength, performance, and muscle growth.
CAS Number: 2446-23-3
TURINOVA (Chlorodehydromethyltestosterone 10 mg) is indicated for therapeutic anabolic support, lean muscle preservation, enhanced strength, and improved athletic recovery. Known for effects similar to Turinabol, it helps improve muscle endurance and performance. Recommended for structured anabolic recovery cycles under medical supervision, TURINOVA is ideal for individuals requiring controlled anabolic support.
TURINOVA by Nova Techsciences is presented as an oral tablet formulation containing Chlorodehydromethyltestosterone, also known as Dehydrochloromethyltestosterone. The compound is identified by CAS Number 2446-23-3 and has the molecular formula C20H27ClO2. It belongs to the synthetic anabolic-androgenic steroid category and is chemically distinct from testosterone, aromatase inhibitors, dopamine agonists and fertility medicines.
This page provides neutral product-identification, quality, regulatory and safety information. It does not replace authorised prescribing information, an approved patient leaflet or guidance from a qualified healthcare professional.
TURINOVA Product Overview
Important identification details include:
- Product name: TURINOVA
- Active compound: Chlorodehydromethyltestosterone
- Alternative name: Dehydrochloromethyltestosterone
- Dosage form: Oral tablet
- CAS Number: 2446-23-3
- Brand: Nova Techsciences
The finished product label should clearly identify the verified tablet strength, complete formulation, inactive ingredients, tablet quantity, batch number, manufacturing date, expiry date and approved storage conditions. Information published online should remain consistent with the product packaging, Certificate of Analysis and batch-release documentation.
Quality Control and Traceability
An oral pharmaceutical product requires documented controls for raw-material identity, active-ingredient concentration, tablet content uniformity, dissolution, impurities, microbiological quality, stability and packaging integrity.
Each TURINOVA batch should carry a unique identification number connected to its manufacturing history and laboratory-release results. Claims relating to pharmaceutical grade, purity, testing or manufacturing standards should only be published when current supporting evidence is available.
For the United Kingdom, the Netherlands and other European markets, Nova Techsciences should clearly disclose the product’s marketing-authorisation status, legal supply category, responsible manufacturer and adverse-event reporting procedure.
Important Safety Information
Chlorodehydromethyltestosterone is an anabolic steroid. The NHS warns that non-medical anabolic-steroid use can cause serious cardiovascular, hormonal, reproductive, liver, kidney and psychological effects and may lead to dependence.
TURINOVA should not be presented for bodybuilding, muscle gain, athletic recovery, unsupervised hormone management or use by minors. Dosage schedules, cycles, combinations or methods intended to reduce adverse effects should not be taken from unofficial sources.
Dehydrochloromethyltestosterone is also listed as a prohibited anabolic agent under the 2026 World Anti-Doping Agency Prohibited List.
Related Nova Techsciences Products
AROMANOVA
AROMANOVA contains Exemestane, identified by CAS Number 107868-30-4. Exemestane is an aromatase inhibitor with specific authorised medical applications. Its product information should separately address prescription status, pregnancy restrictions, bone-health considerations, adverse reactions and applicable market authorisation.
CABERNOVA
CABERNOVA contains Cabergoline, identified by CAS Number 81409-90-7. Cabergoline is a dopamine-receptor agonist used in selected medically supervised circumstances involving prolactin. Its information should cover cardiovascular precautions, contraindications, medicine interactions and appropriate clinical monitoring.
CLOMINOVA
CLOMINOVA contains Clomiphene Citrate, identified by CAS Number 50-41-9. Clomiphene is associated with medically supervised ovulation treatment. Its page should include information about pregnancy restrictions, visual disturbances, ovarian response, liver conditions and professional fertility assessment.
ENCLOMINOVA
ENCLOMINOVA contains Enclomiphene Citrate, identified by CAS Number 7599-79-3. Although chemically related to clomiphene, it is a distinct compound requiring independent evidence, regulatory review, safety documentation and confirmation of its authorised status in each intended market.
FEMANOVA
FEMANOVA contains Letrozole, identified by CAS Number 112809-51-5. Letrozole is an aromatase inhibitor with authorised uses in specific hormone-dependent breast-cancer settings. It is not interchangeable with Exemestane or fertility medicines and requires separate contraindication and monitoring information.
TURINOVA should ultimately be presented through accurate chemical identification, transparent batch documentation, prominent safety information and clearly verified regulatory status rather than performance claims or unnatural keyword repetition.
Important Information & FAQs
Precautions & Contraindications
Precautions
- Use TURINOVA only under the guidance of a qualified healthcare professional.
- Follow recommended dosage; avoid self-medication.
- Inform your doctor of any liver, kidney, heart, or hormonal conditions.
- Periodic blood tests may be required to monitor liver enzymes and hormone levels.
- Avoid alcohol as it may increase liver strain.
- Keep away from children; store in a cool, dry place.
Contraindications
- Do not use if allergic to Chlorodehydromethyltestosterone or any component of TURINOVA.
- Not suitable for individuals with severe liver disease or impaired hepatic function.
- Contraindicated in pregnant or breastfeeding women.
- Avoid in individuals with prostate cancer, breast cancer, or hormone-sensitive conditions.
- Not recommended for uncontrolled hypertension or severe heart conditions.
- Do not combine with other oral hepatotoxic substances or anabolic steroids without medical supervision.
Related Products
AROMANOVA
High-potency Exemestane tablets for advanced estrogen control and PCT support.
CABERNOVA
Premium Cabergoline tablets for prolactin control, hormone support, and enhanced recovery.
CLOMINOVA
Clomiphene Citrate 50 mg tablets for post-cycle therapy, testosterone recovery, and hormonal balance.
ENCLOMINOVA
Premium Enclomiphene Citrate tablets for testosterone boosting, PCT recovery, and hormonal balance.